Fig. 3. (A) Genetic modification of MSCs using recombinant adenoviral (rAd) vectors in the presence of Fe3+ ions to express VEGF-A and HGF. (B) VEGF-A expression levels and (C) HGF expression levels of BMSCs (1 × 105 cells per mL) without and with the mCB[6]/DAH–HA hydrogels on PET membrane transwell inserts (mesh size = 8 μm) for specified periods over 2 weeks (mean ± SD, n = 3, *P < 0.0001).
